598 related articles for article (PubMed ID: 35696844)
1. Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.
Preston EV; Hivert MF; Fleisch AF; Calafat AM; Sagiv SK; Perng W; Rifas-Shiman SL; Chavarro JE; Oken E; Zota AR; James-Todd T
Environ Int; 2022 Jul; 165():107335. PubMed ID: 35696844
[TBL] [Abstract][Full Text] [Related]
2. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
[TBL] [Abstract][Full Text] [Related]
3. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
[TBL] [Abstract][Full Text] [Related]
5. Associations of perfluoroalkyl and polyfluoroalkyl substances with gestational hypertension and blood pressure during pregnancy: A cohort study.
Yang L; Ji H; Liang H; Yuan W; Song X; Li X; Niu J; Shi H; Wen S; Miao M
Environ Res; 2022 Dec; 215(Pt 2):114284. PubMed ID: 36088993
[TBL] [Abstract][Full Text] [Related]
6. First trimester plasma PER- AND Polyfluoroalkyl Substances (PFAS) and blood pressure trajectories across the second and third trimesters of pregnancy.
Burdeau JA; Stephenson BJK; Aris IM; Preston EV; Hivert MF; Oken E; Mahalingaiah S; Chavarro JE; Calafat AM; Rifas-Shiman SL; Zota AR; James-Todd T
Environ Int; 2024 Apr; 186():108628. PubMed ID: 38583297
[TBL] [Abstract][Full Text] [Related]
7. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy.
Huang R; Chen Q; Zhang L; Luo K; Chen L; Zhao S; Feng L; Zhang J
Environ Health; 2019 Jan; 18(1):5. PubMed ID: 30626391
[TBL] [Abstract][Full Text] [Related]
8. Associations of Per- and Polyfluoroalkyl Substances (PFAS) With Glucose Tolerance During Pregnancy in Project Viva.
Preston EV; Rifas-Shiman SL; Hivert MF; Zota AR; Sagiv SK; Calafat AM; Oken E; James-Todd T
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2864-76. PubMed ID: 32480407
[TBL] [Abstract][Full Text] [Related]
9. Perfluoroalkyl and polyfluoroalkyl substances and hypertensive disorders of pregnancy: A systematic review and meta-analysis.
Hu CY; Qiao JC; Gui SY; Xu KX; Dzhambov AM; Zhang XJ
Environ Res; 2023 Aug; 231(Pt 2):116064. PubMed ID: 37178750
[TBL] [Abstract][Full Text] [Related]
10. Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy.
Erinc A; Davis MB; Padmanabhan V; Langen E; Goodrich JM
Environ Res; 2021 Jun; 197():111113. PubMed ID: 33823190
[TBL] [Abstract][Full Text] [Related]
11. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
[TBL] [Abstract][Full Text] [Related]
12. In utero exposure to per-/polyfluoroalkyl substances (PFASs): Preeclampsia in pregnancy and low birth weight for neonates.
Tian Y; Zhou Q; Zhang L; Li W; Yin S; Li F; Xu C
Chemosphere; 2023 Feb; 313():137490. PubMed ID: 36513200
[TBL] [Abstract][Full Text] [Related]
13. Epidemic-specific association of maternal exposure to per- and polyfluoroalkyl substances (PFAS) and their components with maternal glucose metabolism: A cross-sectional analysis in a birth cohort from Hong Kong.
Yang A; Tam CHT; Wong KK; Ozaki R; Lowe WL; Metzger BE; Chow E; Tam WH; Wong CKC; Ma RCW
Sci Total Environ; 2024 Mar; 917():170220. PubMed ID: 38278268
[TBL] [Abstract][Full Text] [Related]
14. Exposure to heavy metals and trace minerals in first trimester and maternal blood pressure change over gestation.
Liu T; Zhang M; Rahman ML; Wang X; Hinkle SN; Zhang C; Mueller NT
Environ Int; 2021 Aug; 153():106508. PubMed ID: 33901931
[TBL] [Abstract][Full Text] [Related]
15. Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: A nested case-control study in Guangxi, China.
Liu B; Wei B; Mo M; Song Y; Tang C; Tang P; Guo X; Tan C; Liu S; Huang D; Qiu X
Chemosphere; 2022 Feb; 288(Pt 1):132468. PubMed ID: 34624345
[TBL] [Abstract][Full Text] [Related]
16. Exploring the impact of prenatal perfluoroalkyl and polyfluoroalkyl substances exposure on blood pressure in early childhood: A longitudinal analysis.
Du B; Wang Q; Xu Z; Wang H; Li Z; Wu Y; Niu Y; Zhang Q; Zhang X; Sun K; Wang J
Ecotoxicol Environ Saf; 2024 Apr; 274():116220. PubMed ID: 38513531
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
Rokoff LB; Wallenborn JT; Harris MH; Rifas-Shiman SL; Criswell R; Romano ME; Young JG; Calafat AM; Oken E; Sagiv SK; Fleisch AF
Sci Total Environ; 2023 Sep; 891():164724. PubMed ID: 37290653
[TBL] [Abstract][Full Text] [Related]
18. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
[TBL] [Abstract][Full Text] [Related]
19. Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort.
Birukov A; Andersen LB; Andersen MS; Nielsen JH; Nielsen F; Kyhl HB; Jørgensen JS; Grandjean P; Dechend R; Jensen TK
Environ Int; 2021 Jun; 151():106442. PubMed ID: 33610053
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
